| Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532649 |
NSE Symbol : NECLIFE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE023H01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 29.98 |
Market Cap(₹Cr) : 213.49 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.01 | 0.00 | 0.00 | 5.87 | 6.15 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.87 | 0.92 | 0.00 |
| Net Sales | 0.01 | 0.00 | 0.00 | 5.00 | 5.23 | 0.00 |
| Other Operating Income | 0.43 | 1.29 | 0.00 | 0.71 | 0.01 | 0.01 |
| Other Income | 6.17 | 6.29 | 35.46 | 0.03 | 0.32 | 0.18 |
| Total Income | 6.62 | 7.58 | 35.46 | 5.74 | 5.56 | 0.18 |
| Total Expenditure | 27.68 | 89.23 | 1.92 | 181.72 | 68.63 | 130.03 |
| PBIDT | -21.07 | -81.65 | 33.53 | -175.98 | -63.07 | -129.85 |
| Interest | 0.16 | 5.90 | 30.22 | 0.00 | 0.00 | 0.00 |
| PBDT | -21.22 | -87.55 | 3.31 | -175.98 | -63.07 | -129.85 |
| Depreciation | 0.11 | 0.08 | 0.06 | 0.20 | 0.53 | 0.30 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -8.20 | -19.71 | -11.02 | -0.18 | -0.37 | -0.06 |
| Reported Profit After Tax | -13.14 | -67.92 | 14.27 | -176.01 | -63.23 | -130.09 |
| Extra-ordinary Items | 0.32 | -30.71 | 34.80 | -175.68 | -62.55 | -129.98 |
| Adjusted Profit After Extra-ordinary item | -13.46 | -37.21 | -20.53 | -0.33 | -0.68 | -0.11 |
| EPS (Unit Curr.) | -2.21 | -3.38 | 0.64 | -7.84 | -2.82 | -5.80 |
| EPS (Adj) (Unit Curr.) | -2.21 | -3.38 | 0.64 | -7.84 | -2.82 | -5.80 |
| Calculated EPS (Unit Curr.) | -0.68 | -3.50 | 0.64 | -7.85 | -2.82 | -5.80 |
| Calculated EPS (Adj) (Unit Curr.) | -0.68 | -3.50 | 0.64 | -7.85 | -2.82 | -5.80 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.70 | -13.98 | 2.55 | -31.39 | -11.28 | -23.20 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.70 | -13.98 | 2.55 | -31.39 | -11.28 | -23.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 19.43 | 19.43 | 22.43 | 22.43 | 22.43 | 22.43 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -210,700.00 | 0.00 | 0.00 | -3,519.60 | -1,205.93 | 0.00 |
| PBDTM(%) | -212,200.00 | 0.00 | 0.00 | -3,519.60 | -1,205.93 | 0.00 |
| PATM(%) | -131,400.00 | 0.00 | 0.00 | -3,520.20 | -1,208.99 | 0.00 |
